Additionally, it is unknown if the elevated HML-2 expression and autoantibodies occurs prior to or following the development of RA, as pro-inflammatory cytokine treatment of fibroblast-like synoviocytes induces the expression of HML-2 and therefore implies that HML-2 activity could simply be the result of RA. Here, CLEC10A is linked to rheumatoid arthritis.